3D Bioprinting: Technologies, Products and Key Application Areas, 2018-2035 - Research and Markets

7. SWOT Analysis

8. Emerging Trends on Social Media

  • Trends on Twitter
  • Popular Keywords and Word Cloud Analysis

9. Recent Trends in 3D Bioprinting Industry

  • Introduction of Scaffold-Free Bioprinting
  • Emergence of 4D Bioprinting: the Next Generation of 3D Bioprinting
  • Use of Stem Cells as Bio Ink
  • Development of UV 3D Bioprinting, a Modified Stereolithography Approach
  • Establishment of Spin-Offs of Academic Institutes
  • Entry of Well-Established Players of 3D Printing Industry in Bioprinting Industry
  • Introduction of Low-Priced Bioprinters
  • Increasing Number of Initiatives Taken by Governments of Different Countries

10. Product Competitiveness Analysis

  • 3D Bioprinters: 2 x 2 Product Competitiveness vs. Supplier Power Analysis

11. Patent Analysis

  • 3D Bioprinting Patents: Distribution by Publication Year
  • 3D Bioprinting Patents: Distribution by Geographical Location
  • 3D Bioprinting Patents: Distribution by CPC Classifications
  • 3D Bioprinting Patents: Emerging Areas
  • 3D Bioprinting Patents: Leading Players

12. Market Forecast and Opportunity Analysis

  • Forecast Methodology
  • Overall 3D Bioprinting Market, 2018-2035
  • 3D Bioprinting Market: Distribution by Applications
  • 3D Bioprinting Market: Distribution by Region (North America, Europe, Asia Pacific and Rest of the World)
  • 3D Bioprinting Market: Distribution by Technology (Extrusion, Inkjet, Laser and Others)

13. Conclusion

  • 3D Bioprinting has Garnered Significant Attention within the Biopharmaceutical Industry
  • The Competitive Market Landscape Features a Mix of Industry and Non-Industry Players
  • North America and Europe Dominate the Current Market; Several Companies based in the Asia Pacific are also Making Notable Progress
  • Research Continues to be the Major Focus as Stakeholders Strive to Improve Existing Methods and Technologies
  • Increasing Partnership Activity and Financial Support from Public and Private Investors are Expected to Drive Growth
  • Recent Advances are Expected to Act as Catalyst to the Success of 3D Bioprinting
  • Inherent Challenges Must be Overcome to Tap the Multi-billion Dollar Opportunity in the Long Term

14. Interview Transcripts

  • Douglas Chrisey, Professor, Tulane University
  • Igor Zlatkin, Application Scientist and Chirantan Kanani, Technology & Product Development, Digilab
  • Fanny Geraldo and Lisa Oliver, Researchers, University of Nantes
  • Glauco R Souza, President & Chief Scientific Officer and Hubert Tseng, Senior Research Scientist, n3D Biosciences
  • Kenneth Church, President & Chief Executive Officer and Xudong Chen, Executive Vice President Business Development & Sales, nScrypt
  • Laura Bosworth, Chief Executive Officer & Co-Founder, TeVido BioDevices
  • Lauralyn McDaniel, Industrial Manager, SME
  • Marc Thurner, Chief Executive Officer, regenHU
  • Roger Narayan, Professor, North Carolina State University
  • Simon Fried, Chief Business Officer, Nano Dimension
  • Anonymous, MicroFab Technologies




Review Article Be the first to review this article



© 2018 Internet Business Systems, Inc.
25 North 14th Steet, Suite 710, San Jose, CA 95112
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise